Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes

E L Hannan1, D T Arani, L W Johnson

  • 1Department of Health Policy and Management, State University of New York, Albany.

JAMA
|December 12, 1992
PubMed

Insights

Identifying risk factors for percutaneous transluminal coronary angioplasty (PTCA) outcomes is crucial. Female gender, hemodynamic instability, shock, and ejection fraction were significant independent predictors of adverse PTCA events.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery disease.
  • Identifying factors that predict PTCA outcomes is essential for patient management and risk stratification.

Purpose of the Study:

  • To identify significant independent risk factors associated with major adverse outcomes following percutaneous transluminal coronary angioplasty.
  • To analyze preprocedural variables that influence in-hospital mortality, major complications, and angiographic success.

Main Methods:

  • Retrospective analysis of 5,827 patients undergoing PTCA in New York State between January 1, 1991, and June 30, 1991.
  • Univariate and logistic regression analyses were employed to identify independent risk factors for adverse outcomes.

Main Results:

  • In-hospital mortality was 0.63%, major complications occurred in 3.2% of patients, and angiographic success was achieved in 88%.
  • Independent preprocedural predictors of death included female gender, hemodynamic instability, shock, and ejection fraction.
  • Emergency coronary artery bypass graft surgery was performed in 1.7% of patients, with a higher mortality rate in hemodynamically unstable patients.

Conclusions:

  • Outcomes of PTCA in New York during the study period were comparable to other reported results.
  • Specific preprocedural variables significantly increase the risk of adverse events during PTCA, highlighting the importance of patient selection and risk assessment.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...